Status:
COMPLETED
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Lymphoma, Lymphoblastic
Eligibility:
All Genders
15-65 years
Phase:
PHASE4
Brief Summary
This study evaluates the efficacy and tolerability of treatment for T-lymphoblastic lymphoma (T-LBL) according to a protocol for acute lymphoblastic leukemia. Patients receive one year of intensive cy...
Eligibility Criteria
Inclusion
- T-lymphoblastic lymphoma (bone marrow \[BM\] involvement \< 25%)
- Aged 15-65 years (55-65 years if biologically younger)
- Written informed consent
Exclusion
- Severe complications due to lymphoma or secondary disease
- T-LBL as second malignancy or other active second malignancy
- Cytostatic pretreatment of LBL (exception of emergency treatments)
- Pregnancy
- Severe psychiatric illness or other circumstances which may compromise cooperation of the patient or informed consent
- Participation in other study interfering with study treatment
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00199017
Start Date
April 1 2004
Last Update
August 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital, Medical Dept. II
Frankfurt, Germany, 60590